Search research articles
Contact Us
Filters
Showing results (191-200 of 235) with videos related to
Page
of 24
Sort By:
Scientific Reports
|
October 29, 2024
Transcriptome reanalysis and gene expression of 13 detoxification genes for avermectin and pyridaben resistance in Panonychus citri
Xiaoqing Han, Mengyuan Peng, Yunlong Zhang, et al.
Targeted Oncology
|
July 1, 2021
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
Jiani Wang, Qingyuan Zhang, Qiao Li, et al.
Medicine
|
June 24, 2016
Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study
Yang Ni, Jingwang Bi, Xin Ye, et al.
Journal of Cancer Research and Therapeutics
|
July 5, 2018
Computed tomography-guided percutaneous microwave ablation for treatment of peripheral ground-glass opacity-Lung adenocarcinoma: A pilot study
Xia Yang, Xin Ye, Zhengyu Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 2017
Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production
Masaki Nakamura, Yin Zhang, Yunlong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2020
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Xinan Sheng, Xieqiao Yan, Lin Wang, et al.
Cell Metabolism
|
February 20, 2025
Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation
Weijie Wu, Wenhai Sui, Sizhe Chen, et al.
International Journal of Cancer
|
August 16, 2025
A multicenter randomized controlled trial of intrapleural perfusion of methotrexate-loaded tumor cell-derived microparticles combined with systemic therapy for malignant pleural effusion
Cheng Zeng, Yujing Tan, Zhimin Jiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2023
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials
Xinan Sheng, Lin Wang, Zhisong He, et al.
Journal of the National Cancer Center
|
July 22, 2024
Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer
Huizi Lei, Yun Ling, Pei Yuan, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 235) with videos related to
Sort By:
Page
of 24
Scientific Reports
|
October 29, 2024
Transcriptome reanalysis and gene expression of 13 detoxification genes for avermectin and pyridaben resistance in Panonychus citri
Xiaoqing Han, Mengyuan Peng, Yunlong Zhang, et al.
Targeted Oncology
|
July 1, 2021
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
Jiani Wang, Qingyuan Zhang, Qiao Li, et al.
Medicine
|
June 24, 2016
Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study
Yang Ni, Jingwang Bi, Xin Ye, et al.
Journal of Cancer Research and Therapeutics
|
July 5, 2018
Computed tomography-guided percutaneous microwave ablation for treatment of peripheral ground-glass opacity-Lung adenocarcinoma: A pilot study
Xia Yang, Xin Ye, Zhengyu Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 2017
Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production
Masaki Nakamura, Yin Zhang, Yunlong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2020
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Xinan Sheng, Xieqiao Yan, Lin Wang, et al.
Cell Metabolism
|
February 20, 2025
Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation
Weijie Wu, Wenhai Sui, Sizhe Chen, et al.
International Journal of Cancer
|
August 16, 2025
A multicenter randomized controlled trial of intrapleural perfusion of methotrexate-loaded tumor cell-derived microparticles combined with systemic therapy for malignant pleural effusion
Cheng Zeng, Yujing Tan, Zhimin Jiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2023
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials
Xinan Sheng, Lin Wang, Zhisong He, et al.
Journal of the National Cancer Center
|
July 22, 2024
Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer
Huizi Lei, Yun Ling, Pei Yuan, et al.
Page
of 24